Helander, A; Böttcher, M; Fehr, C et al.
Detection times for urinary ethyl glucuronide and ethyl sulfate in heavy drinkers during alkohol detoxificationAlcohol Alcohol. Bd. 44. H. 1. 2009 S. 55-61
Garcia-Cabellero, T; Grabau, D; Green, AR et al.
Determination of HER2 amplification in primary breast cancer using dual-color chromogenic in situ hybridization is comparable to fluorescence in situ hybridization: a European multicenter study involving 168 specimens.Histopathology. 2009 S. 01
Nagels, S; Hampel, G; Kratz, JV et al.
Determination of the irradiation field at the research reactor TRIGA Mainz for BNCT.Appl Radiat Isot. Bd. 67. H. 7-8 Suppl. 2009 S. S242-6
Montermann, E.; Martin, H.; Grabbe, S. et al.
Determination of the tolerogenic potential of dexamethasone-treated antigen-presenting cells by in vivo MLREuropean Journal of Immunology. Bd. 39. H. 1. 2009 S. 652-652
Conzelmann, LO; Dapunt, O; Kallenbach, K et al.
Deutsches Register für akute Aortendissektion Typ A (GERAADA)-Motiv, Entwicklung, erste Erkenntnisse und VisionZ Herz, Thorax Gefäßchir. 2009 S. in press1
Atreya, I; Diall, A; Ostrau, C et al.
Development and In Vivo Analysis of a New Generation of Optimized Thio-GTP Analogues for Therapy of IBDGASTROENTEROLOGY. Bd. 136. H. 5. 2009 S. A406-A406
Eidens, M; Weise, A; Prause, S et al.
Development and validation of a high-throughput screening method for two polymorphisms in the serotonin transporter gene.Mol Diagn Ther. Bd. 13. H. 1. 2009 S. 25-9
Zehbe, R; Brochhausen, C; Haibel, A et al.
Development of a combined drug release- and scaffold-system for articular regeneration.Mater Sci Res J. Bd. 2. 2009 S. 169-190
Schnabel, RB; Sullivan, LM; Levy, D et al.
Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort studyLANCET. Bd. 373. H. 9665. 2009 S. 739-745
Keller, K; Boehm, D; Lebrecht, A et al.
Development of a tool for reversed-phase protein microarrays (RPMA) and use in immunoproteomics of breast cancerEur J Cancer. Bd. 27. 2009 S. e22186